Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

316
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
316
Dose-Response Relationship: Overview01:03

Dose-Response Relationship: Overview

4.6K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
4.6K
Hazard Rate01:11

Hazard Rate

330
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
330
Relative Risk01:12

Relative Risk

1.5K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.5K
Quantitative Aspects of Drug-Receptor Interaction01:30

Quantitative Aspects of Drug-Receptor Interaction

1.6K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.6K
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

903
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
903

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inorganic arsenic exposure and modifying factors: a systematic evidence map.

Human and ecological risk assessment : HERA·2026
Same author

A hierarchical constrained density regression model for predicting cluster-level dose-response.

Environmetrics·2025
Same author

Estimation of benchmark dose ratio distributions for subchronic-to-chronic extrapolation using meta-analysis.

Toxicological sciences : an official journal of the Society of Toxicology·2025
Same author

Lung cancer risk assessment associated with exposure to hexavalent chromium: Results of pooled analysis of three cohorts.

Journal of occupational and environmental hygiene·2025
Same author

Dose-response modeling of effects in mice after exposure to a polyfluoroalkyl substance (Nafion byproduct 2).

Toxicological sciences : an official journal of the Society of Toxicology·2025
Same author

Lung cancer mortality among aircraft manufacturing workers with long-term, low-level, hexavalent chromium exposure.

Journal of occupational and environmental hygiene·2025

Related Experiment Video

Updated: Dec 17, 2025

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.0K

Quantitative Risk Assessment: Developing a Bayesian Approach to Dichotomous Dose-Response Uncertainty.

Matthew W Wheeler1, Todd Blessinger2, Kan Shao3

  • 1Biostatistics and Computational Biology Branch, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA.

Risk Analysis : an Official Publication of the Society for Risk Analysis
|July 1, 2020
PubMed
Summary

This study introduces a novel Bayesian approach for estimating the benchmark dose (BMD) in dose-response modeling. The new method offers accurate, reproducible, and fast estimations for dichotomous data, outperforming traditional single-model approaches.

Keywords:
Benchmark dose estimationMonte Carlo simulationmaximum a posteriori estimationquantitative risk estimation

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.3K

Related Experiment Videos

Last Updated: Dec 17, 2025

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay
06:25

Author Spotlight: High-Throughput Toxicity Screening Using Zebrafish Embryo Startle Response Assay

Published on: January 12, 2024

2.0K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.4K
Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods
13:04

Measuring the Subjective Value of Risky and Ambiguous Options using Experimental Economics and Functional MRI Methods

Published on: September 19, 2012

12.3K

Area of Science:

  • Toxicology
  • Biostatistics
  • Risk Assessment

Background:

  • Model averaging is preferred for benchmark dose (BMD) estimation but faces implementation challenges.
  • Existing Bayesian methods lack informative priors for models and parameters.
  • High-throughput data analysis requires efficient dose-response estimation methods.

Purpose of the Study:

  • Introduce a novel, fully Bayesian framework for dichotomous dose-response estimation.
  • Address challenges in implementing model averaging and Bayesian methods.
  • Provide accurate, reproducible, and fast BMD estimation.

Main Methods:

  • Developed a novel Bayesian framework for dichotomous dose-response modeling.
  • Approximated posterior density using maximum a posteriori (MAP) estimation, avoiding computationally intensive Markov Chain Monte Carlo (MCMC) methods.
  • Applied the method to empirical laboratory dose-response data.

Main Results:

  • The novel Bayesian approach provides accurate and reproducible BMD estimates.
  • MAP estimation offers speed comparable to maximum likelihood estimation.
  • The method demonstrated superior performance compared to single-model selection in simulations.
  • Coverage of confidence limits for BMD was accurately measured.

Conclusions:

  • The proposed Bayesian method is a significant improvement over traditional single-model approaches for dichotomous dose-response analysis.
  • It offers a computationally efficient and accurate alternative for BMD estimation, suitable for large datasets.
  • This approach enhances the feasibility of model averaging in risk assessment applications.